Jian Wu (J Wu)

ORCID

Publication Activity (10 Years)

Years Active: 2015-2024
Publications (10 Years): 23

Top Venues

Acta pharmacologica Sinica

Gut microbes

Clinical and translational medicine

Advanced materials (Deerfield Beach, Fla.)

Fudan University Shanghai Medical College

University of Umea (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Fudan University Shanghai Medical College

China

Professor :: School of Basic Medical Sciences

University of California Davis

United States

Assistant/Associate and Full Professor :: School of Medicine/Dept. of Internal Medicine/GI & Hepatology

Thomas Jefferson University Jefferson Medical College

United States

Post-doctoral Scientist (NIH-Supported) :: Dept. of Medicine/GI & Hepatology

Umea University Faculty of Medicine

Sweden

Assistant Research Professor :: Cell Biology, Clinical Chemistry & Medicine

Southeast University Zhongda Hospital

China

Resident/chief/Attending Physician/Lecturer :: Dept. of Internal Medicine/Division of GI & Hepatology

Education History

University of Umea

Sweden

PHD :: Faculty of Medicine

Southeast University Medical College

China

MSC :: Dept. of Internal Medicine/GI & Hepatology

Nantong Medical College

China

BSC :: Clinical Medicine

Publications

Li Zhang, Yong-Yu Yang, Li Xie, Yuan Zhou, Zhenxing Zhong, Jia Ding, Zhong-Hua Wang, Yu-Li Wang, Xiu-Ping Liu, Fa-Xing Yu, Jian Wu
JCAD deficiency delayed liver regenerative repair through the Hippo-YAP signalling pathway. Clinical and translational medicine 14 (3) (2024)
Li Zhang, Yong-Yu Yang, Li Xie, Yuan Zhou, Zhenxing Zhong, Jia Ding, Zhong-Hua Wang, Yu-Li Wang, Xiu-Ping Liu, Fa-Xing Yu, Jian Wu
JCAD deficiency delayed liver regenerative repair through the Hippo-YAP signalling pathway. Clinical and translational medicine 14 (3) (2024)
Cheng Jin, Hui Chen, Li Xie, Yuan Zhou, Li-Li Liu, Jian Wu
GPCRs involved in metabolic diseases: pharmacotherapeutic development updates. Acta pharmacologica Sinica 45 (7) (2024)
Li Zhang, Yong-Yu Yang, Li Xie, Yuan Zhou, Zhenxing Zhong, Jia Ding, Zhong-Hua Wang, Yu-Li Wang, Xiu-Ping Liu, Fa-Xing Yu, Jian Wu
JCAD deficiency delayed liver regenerative repair through the Hippo-YAP signalling pathway. Clinical and translational medicine 14 (3) (2024)
Cheng Jin, Hui Chen, Li Xie, Yuan Zhou, Li-Li Liu, Jian Wu
GPCRs involved in metabolic diseases: pharmacotherapeutic development updates. Acta pharmacologica Sinica (2024)
Yu-Li Wang, Chang Liu, Yong-Yu Yang, Li Zhang, Xiao Guo, Chen Niu, Ning-Ping Zhang, Jia Ding, Jian Wu
Dynamic changes of gut microbiota in mouse models of metabolic dysfunction-associated steatohepatitis and its transition to hepatocellular carcinoma. FASEB journal : official publication of the Federation of American Societies for Experimental Biology 38 (13) (2024)
Cheng Jin, Hui Chen, Li Xie, Yuan Zhou, Li-Li Liu, Jian Wu
GPCRs involved in metabolic diseases: pharmacotherapeutic development updates. Acta pharmacologica Sinica 45 (7) (2024)
Li Zhang, Yong-Yu Yang, Li Xie, Yuan Zhou, Zhenxing Zhong, Jia Ding, Zhong-Hua Wang, Yu-Li Wang, Xiu-Ping Liu, Fa-Xing Yu, Jian Wu
JCAD deficiency delayed liver regenerative repair through the Hippo-YAP signalling pathway. Clinical and translational medicine 14 (3) (2024)
Cheng Jin, Hui Chen, Li Xie, Yuan Zhou, Li-Li Liu, Jian Wu
GPCRs involved in metabolic diseases: pharmacotherapeutic development updates. Acta pharmacologica Sinica 45 (7) (2024)
Huiyan Li, Huilin Zhang, Xiaofang He, Peiran Zhao, Tong Wu, Jinxuan Xiahou, Yelin Wu, Yanyan Liu, Yang Chen, Xingwu Jiang, Guanglei Lv, Zhenwei Yao, Jian Wu, Wen-Bo Bu
Blocking Spatiotemporal Crosstalk between Subcellular Organelles for Enhancing Anticancer Therapy with Nanointercepters. Advanced materials (Deerfield Beach, Fla.) (2023)
Huiyan Li, Huilin Zhang, Xiaofang He, Peiran Zhao, Tong Wu, Jinxuan Xiahou, Yelin Wu, Yanyan Liu, Yang Chen, Xingwu Jiang, Guanglei Lv, Zhenwei Yao, Jian Wu, Wen-Bo Bu
Blocking Spatiotemporal Crosstalk between Subcellular Organelles for Enhancing Anticancer Therapy with Nanointercepter. Advanced materials (Deerfield Beach, Fla.) (2023)
Yong-Yu Yang, Li Xie, Ning-Ping Zhang, Da Zhou, Tao-Tao Liu, Jian Wu
Updates on novel pharmacotherapeutics for the treatment of nonalcoholic steatohepatitis. Acta pharmacologica Sinica 43 (5) (2022)
Yue Shen, Sheng-Di Wu, Yao Chen, Xin-Yue Li, Qin Zhu, Kiyoko Nakayama, Wan-Qin Zhang, Cheng-Zhao Weng, Jun Zhang, Hai-Kun Wang, Jian Wu, Wei Jiang
Alterations in gut microbiome and metabolomics in chronic hepatitis B infection-associated liver disease and their impact on peripheral immune response. Gut microbes 15 (1) (2022)
Yue Shen, Sheng-Di Wu, Yao Chen, Xin-Yue Li, Qin Zhu, Kiyoko Nakayama, Wan-Qin Zhang, Cheng-Zhao Weng, Jun Zhang, Hai-Kun Wang, Jian Wu, Wei Jiang
Alterations in gut microbiome and metabolomics in chronic hepatitis B infection-associated liver disease and their impact on peripheral immune response. Gut microbes 15 (1) (2022)
Yue Shen, Sheng-Di Wu, Yao Chen, Xin-Yue Li, Qin Zhu, Kiyoko Nakayama, Wan-Qin Zhang, Cheng-Zhao Weng, Jun Zhang, Hai-Kun Wang, Jian Wu, Wei Jiang
Alterations in gut microbiome and metabolomics in chronic hepatitis B infection-associated liver disease and their impact on peripheral immune response. Gut microbes 15 (1) (2022)
Yue Shen, Sheng-Di Wu, Yao Chen, Xin-Yue Li, Qin Zhu, Kiyoko Nakayama, Wan-Qin Zhang, Cheng-Zhao Weng, Jun Zhang, Hai-Kun Wang, Jian Wu, Wei Jiang
Alterations in gut microbiome and metabolomics in chronic hepatitis B infection-associated liver disease and their impact on peripheral immune response. Gut microbes 15 (1) (2022)
Yue Shen, Sheng-Di Wu, Yao Chen, Xin-Yue Li, Qin Zhu, Kiyoko Nakayama, Wan-Qin Zhang, Cheng-Zhao Weng, Jun Zhang, Hai-Kun Wang, Jian Wu, Wei Jiang
Alterations in gut microbiome and metabolomics in chronic hepatitis B infection-associated liver disease and their impact on peripheral immune response. Gut microbes 15 (1) (2022)
Chang Liu, Yu-Li Wang, Yong-Yu Yang, Ning-Ping Zhang, Chen Niu, Xi-Zhong Shen, Jian Wu
Novel approaches to intervene gut microbiota in the treatment of chronic liver diseases. FASEB journal : official publication of the Federation of American Societies for Experimental Biology 35 (10) (2021)
Jia Ding, Hui-Yan Li, Li Zhang, Yuan Zhou, Jian Wu
Hedgehog Signaling, a Critical Pathway Governing the Development and Progression of Hepatocellular Carcinoma. Cells 10 (1) (2021)
Xiao-Tian Zhou, Jia Ding, Hui-Yan Li, Jie-Liang Zuo, Sheng-Yang Ge, Hu-Liang Jia, Jian Wu
Hedgehog signalling mediates drug resistance through targeting TAP1 in hepatocellular carcinoma. Journal of cellular and molecular medicine 24 (7) (2020)
Mei Wu, Yang Zhou, Sheng-Lan Qin, Li-Jing Lin, Jian Ping, Zhang Tao, Jing Zhang, Lie-Ming Xu, Jian Wu
Fuzheng Huayu Capsule Attenuates Hepatic Fibrosis by Inhibiting Activation of Hepatic Stellate Cells. Evidence-based complementary and alternative medicine : eCAM 2020 (2020)
Xue-Jing Liu, Li Xie, Kuo Du, Chang Liu, Ning-Ping Zhang, Chen-Jian Gu, Ying Wang, Manal F Abdelmalek, Wen-Yue Dong, Xiu-Ping Liu, Chen Niu, Chen Yang, Anna Mae Diehl, Jian Wu
Succinate-GPR-91 receptor signalling is responsible for nonalcoholic steatohepatitis-associated fibrosis: Effects of DHA supplementation. Liver international : official journal of the International Association for the Study of the Liver 40 (4) (2020)
Di Ding, Lin-Lin Chen, Ying-Zhen Zhai, Chen-Jian Hou, Li-Li Tao, Shu-Han Lu, Jian Wu, Xiu-Ping Liu
Trichostatin A inhibits the activation of Hepatic stellate cells by Increasing C/EBP-α Acetylation in vivo and in vitro. Scientific reports 8 (1) (2018)
Y-H Fan, J Ding, S Nguyen, X-J Liu, G Xu, H-Y Zhou, N-N Duan, S-M Yang, M A Zern, Jian Wu
Aberrant hedgehog signaling is responsible for the highly invasive behavior of a subpopulation of hepatoma cells. Oncogene 35 (1) (2015)

Jian Wu.css-eqlu8i{font-size:small;padding-left:4px;} (J Wu)

Publication Activity (10 Years)

Top Topics

Top Venues

Jian Wu (J Wu)